🕵️ Hemab Therapeutics Holdings, Inc. ($COAG)
SEC insider & ownership activity, last 12 months · CIK 2114044 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
1 buyer, value withheld pending verification (16 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 16 | value withheld pending verification | 0 | – | Jun 16, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 16.6% | 13G | May 11, 2026 | filing ↗ | |
| Peter Kolchinsky | 16.6% | 13G | May 11, 2026 | filing ↗ | |
| Rajeev Shah | 16.6% | 13G | May 11, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 13.6% | 13G | May 11, 2026 | filing ↗ | |
| Access Industries Holdings LLC | 10.4% | 13D | May 4, 2026 | filing ↗ | |
| AI Den-Mab LLC | 10.4% | 13D | May 4, 2026 | filing ↗ | |
| Access Industries Management LLC | 10.4% | 13D | May 4, 2026 | filing ↗ | |
| Len Blavatnik | 10.4% | 13D | May 4, 2026 | filing ↗ | |
| AI Biotechnology LLC | 10.4% | 13D | May 4, 2026 | filing ↗ | |
| NOVO Holdings A/S | 9.0% | 13G | Aug 14, 2026 | filing ↗ | |
| DEEP Track Capital, LP | 8.2% | 13G | May 8, 2026 | filing ↗ | |
| David Kroin | 8.2% | 13G | May 8, 2026 | filing ↗ | |
| FMR LLC | 7.9% | 13G | Aug 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 7.9% | 13G | Aug 6, 2026 | filing ↗ | |
| Capital International Investors | 7.7% | 13G | Aug 12, 2026 | filing ↗ | |
| Behzad Aghazadeh | 7.1% | 13G | Aug 14, 2026 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 6.8% | 13G | May 8, 2026 | filing ↗ | |
| Sofinnova Crossover II Slp | 5.4% | 13G | Aug 5, 2026 | filing ↗ | |
| Sofinnova Partners SAS, A French Corporation | 5.4% | 13G | Aug 5, 2026 | filing ↗ | |
| Antoine Papiernik | 5.4% | 13G | Aug 5, 2026 | filing ↗ | |
| Cedric Moreau | 5.4% | 13G | Aug 5, 2026 | filing ↗ | |
| Kinam Hong | 5.4% | 13G | Aug 5, 2026 | filing ↗ | |
| Joseph Anderson | 5.4% | 13G | Aug 5, 2026 | filing ↗ | |
| David Evans | 5.4% | 13G | Aug 5, 2026 | filing ↗ | |
| Raymond Debbane | 5.1% | 13G | Aug 7, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Earnings (2.02) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 8, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 4, 2026 | filing ↗ |
| Other events (8.01) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |